Cancer Registry Software Market From Data to Progress: How Cancer Registry Software is Driving Market Growth

Cancer Registry Software Market worth $181.84 Mn by 2031- Exclusive Report by InsightAce Analytic Pvt. Ltd.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cancer Registry Software Market- (By Software Type (Standalone Software, Integrated Software), By Database (Public data, Commercial data), By Deployment Model (Cloud-based, On-premises), By Functionality (Cancer reporting to meet federal regulations, Patient care management, Product outcome evaluation,

Medical research and clinical studies), By End-User (Government organisation and third-party administrator, Hospitals and medical practices, Research centres, Pharmaceutical, Biotechnology companies & medical device companies, Private players, Research centres)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Cancer Registry Software Market is valued at US$ 76.07 Mn in 2022, and it is expected to reach US$ 181.84 Mn by 2031, with a CAGR of 10.3% during a forecast period of 2024-2031.

Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1992

The Importance of Cancer Registries
Cancer registries play a vital role in both upholding and improving patient care while assisting with critical clinical research. The majority of countries track cancer cases using two main types of registries: hospital-based and population-based.

Benefits of Population-Based Registries
Government organizations establish population-based registries to achieve a variety of goals, including:
• Early detection of cancer
• Understanding cancer trends
• Cancer prevention
• Researching treatment and predictive patterns
• Managing cancer as a disease

These registries offer a cost-effective way to evaluate cancer prevention programs and ultimately reduce cancer-related problems across entire countries and regions.

Market Growth Drivers
The need to control the growing burden of cancer is a major driver behind the exponential growth in the number of cancer registries. Rising cancer prevalence, along with the potential for improved healthcare quality, lower healthcare costs, and advancements in the field, are expected to further fuel market expansion in the near future. This includes recent moves by major players in the market, such as product launches and mergers & acquisitions.

Digital Solutions and Challenges
The adoption of digital solutions for cancer registries offers several advantages. These solutions can improve infrastructure and reduce overall expenses by providing a more economical and effective approach. However, there are also challenges that may hinder market growth. Concerns about patient data security and privacy are significant hurdles that need to be addressed. Additionally, the lack of resources for many healthcare facilities to implement state-of-the-art software solutions could limit the overall growth of the cancer registry software market.

The Role of Public and Commercial Registries
Both public and commercial cancer registries contribute to the advancement of sophisticated cancer registry software and ultimately enhance data quality. Research organizations and pharmaceutical companies heavily rely on cancer registries as a follow-up source for phase III and IV clinical studies. Improved clinical research and healthcare assessment, fueled by better data from cancer registries, will ultimately play a role in reducing the global cancer burden and accelerate market expansion during the forecast period.

List of Prominent Players in the Cancer Registry Software Market:
• Elekta (Sweden),
• Electronic Registry Systems, Inc. (US),
• Onco, Inc. (US),
• C/NET Solutions (US),
• Rocky Mountain Cancer Data Systems (US),
• McKesson Corporation (US)

Market Dynamics:
Drivers-
The market for cancer registry software is expanding at an accelerated rate due to increased attention being paid to developing high-quality healthcare facilities and reducing the costs associated with providing that care. The market is also benefiting from numerous effective initiatives by governmental bodies to lower cancer incidences and the high adoption rate for this software. The global cancer registry software market is expanding due to the rising incidence of cancer occurrences.

One of the most prevalent chronic diseases, cancer is also one of the leading causes of death today. The main contributors to the increase in cancer cases are dietary changes, environmental factors, including pollution and tobacco use, and genetic alterations. The rising incidence of such factors worldwide has been directly attributed to their rising prevalence. As a result, cancer is now the second most common cause of death globally.

Challenges:
The development of the worldwide cancer registry software industry is hampered by a serious issue called lack of interoperability. Cancer registries primarily aid in patient care by disseminating precise and convenient information regarding patients, their medical interventions, and the outcomes attained.

Additionally, multiple EHR systems are largely used by hospitals and cancer centres, which could result in inefficiencies in the clinical process. A significant obstacle in oncology is the direct integration of cancer registries with EHR systems. The lack of interoperability with (EHR) systems in pull-out data from cancer registries is a challenge that can restrict the demand for cancer registry software. This is expected to impede the growth of the global cancer registry software market during the forecast period.

Regional Trends:
The North American cancer registry software market is expected to register a major market share. The market in the region is anticipated to be driven by new product launches and the rising prevalence of chronic diseases like cancer. Similarly, expanding the use of cancer registries would spur market expansion. Many cancer registries now use Registry Plus products as their standard operating system because they help them comply with NPCR's electronic data-sharing requirements while streamlining and automating registry operations. A high adoption rate would spur market expansion shortly.

Besides, the Asia Pacific region had a substantial share of the market beacause of factors such as a growing population, rapid urbanization, and increasing industrialization. Additionally, the market is expected to be driven by the (R&D) activities undertaken by prominent players in the industry.

Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/1992

Recent Developments:
• In Sept 2022, Nursenav Inc. and Electronic Registry Systems (ERS) Inc. collaborated to connect their two most prominent software products, CRStar and CONNECT. In order to complement the services offered by oncology navigation, this integration made use of cancer registry workflows and data collecting.

• In December 2020, McKesson started Ontada, an oncology technology and insights business that aims to help improve cancer research and care. Ontada was in a unique situation to improve cancer care by allowing deep collaboration between life sciences companies and oncology providers.

Segmentation of Cancer Registry Software Market-
By Software Type
• Standalone Software
• Integrated Software
By Database
• Public data
• Commercial data
By Deployment Model
• Cloud-based
• On-premises
By Functionality
• Cancer reporting to meet federal regulations.
• Patient care management
• Product outcome evaluation
• Medical research and clinical studies
By End-User-
• Government organization and third-party administrator
• Hospitals and medical practices
• Research centers
• Pharmaceutical, Biotechnology companies & medical device companies
• Private players
• Research centers
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

For More Customization @ https://www.insightaceanalytic.com/report/cancer-registry-software-market/1992

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.